BDSI BioDelivery Sciences International Inc.

-0.01  -0%
Previous Close 4.36
Open 4.35
Price To Book 14.03
Market Cap 389,383,869
Shares 89,513,533
Volume 526,024
Short Ratio
Av. Daily Volume 885,163

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data released December 13, 2016 - primary endpoints not met.
Clonidine gel
Painful diabetic neuropathy (PDN)
Approved June 6, 2014.
BEMA Buprenorphine/Naloxone (BNX) - BUNAVAIL
Opioid dependence
Approved October 26, 2015.
BEMA Buprenorphine

Latest News

  1. What Makes BioDelivery (BDSI) a New Strong Buy Stock
  2. BioDelivery Sciences Expands Upon Report from Pain Management Task Force
  3. The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International
  4. 5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints
  5. BioDelivery Sciences Named to the Russell 3000® Index
  6. Here’s What Hedge Funds Think About BioDelivery Sciences International, Inc. (BDSI)
  7. Why Is BioDelivery (BDSI) Down 12.3% Since Last Earnings Report?
  8. Triangle company uses new financial strength to lock down favorable loan
  9. BioDelivery Sciences Announces Upcoming Investor Conference Presentations
  10. BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
  11. Can You Imagine How Chuffed BioDelivery Sciences International's (NASDAQ:BDSI) Shareholders Feel About Its 108% Share Price Gain?
  12. The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology
  13. 5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon
  14. All You Need to Know About BioDelivery (BDSI) Rating Upgrade to Buy
  15. Edited Transcript of BDSI earnings conference call or presentation 6-May-19 8:30pm GMT
  16. BioDelivery (BDSI) Stock Up on Q1 Earnings and Sales Beat
  17. BioDelivery Sciences International, Inc. (BDSI) Q1 2019 Earnings Call Transcript
  18. BioDelivery Sciences International (BDSI) Reports Q1 Loss, Tops Revenue Estimates
  19. BioDelivery: 1Q Earnings Snapshot
  20. BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations